Association of CLU and PICALM variants with Alzheimer's disease

Neurobiol Aging. 2012 Mar;33(3):518-21. doi: 10.1016/j.neurobiolaging.2010.04.015. Epub 2010 Jun 8.

Abstract

Two recent large genome-wide association studies have reported significant associations in the CLU (APOJ), CR1, and PICALM genes with the risk of Alzheimer's disease (AD). In order to replicate these findings, we examined 7 single nucleotide polymorphisms (SNPs) most significantly implicated by these studies in a large case-control sample comprising 2707 individuals. Principle components analysis revealed no population substructure in our sample. While no association was observed with CR1 SNPs (p = 0.30-0.457), a trend of association was seen with the PICALM (p = 0.071-0.086) and CLU (p = 0.148-0.258) SNPs. A meta-analysis of 3 studies revealed significant associations with all 3 genes. Our data from an independent and large case-control sample suggest that these gene regions should be followed up by comprehensive resequencing to find functional variants.

Publication types

  • Meta-Analysis
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / physiopathology
  • Case-Control Studies
  • Clusterin / genetics*
  • Female
  • Genetic Predisposition to Disease / genetics*
  • Genome-Wide Association Study / methods
  • Genotype
  • Humans
  • Male
  • Monomeric Clathrin Assembly Proteins / genetics*
  • Polymorphism, Single Nucleotide / genetics*

Substances

  • CLU protein, human
  • Clusterin
  • Monomeric Clathrin Assembly Proteins
  • PICALM protein, human